NH TherAguix SAS   Report issue

For profit Phase 2
Founded: Villeurbanne France (2015)

Organization Overview

First Clinical Trial
2016
NCT02820454
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

NH TherAguix SAS